Screen Validation Clause Samples
The Screen Validation clause establishes requirements for verifying the accuracy and functionality of display screens or user interfaces within a product or system. Typically, this involves testing screens to ensure they present information correctly, respond to user inputs as intended, and meet specified design or regulatory standards. By mandating such validation, the clause helps prevent errors, enhances user experience, and ensures compliance, thereby reducing the risk of operational issues or user dissatisfaction.
Screen Validation. When Aurora completes the development of a Screen which meets the applicable Validation Criteria, it shall provide the CC with a written report describing the Screen and the data demonstrating compliance with the Screen Development Plan and applicable Validation Criteria and Aurora will submit to Allelix an invoice for *** ). Within thirty (30) days of receipt of such invoice, provided that Aurora has satisfied its obligations under this Section 2.2, Allelix will pay Aurora *** ).
Screen Validation. When Aurora completes the development of a Collaborative Screen, ***
Screen Validation. Novartis will be responsible for the growth and treatment of cells associated with Screen Validation. Novartis will provide Avalon frozen cell lysates of compound-treated cells according to protocols agreed between the Parties. ¡ An initial set of *** Novartis Compounds will be selected by Novartis for screening. The data obtained from this initial set of compounds will be reviewed by both Avalon and Novartis to ensure acceptable performance of the screen. Upon the satisfactory review of this data, Novartis will approve the screening of the remaining *** compounds.
Screen Validation. When Aurora completes the development of a Collaborative Screen, it shall provide the CSP Steering Committee with a written report describing the Collaborative Screen and the data demonstrating compliance with the CSP Work Plan including the validation criteria. Aurora will also permit Merck representatives to visit the facilities of Aurora to test and verify compliance of the Collaborative Screen with the validation criteria. Merck, through the CSP Steering Committee, will approve the report and accept the Collaborative Screen, or provide Aurora a written explanation for declining such acceptance within thirty (30) days of receipt of the report by committee members. Upon acceptance of each Collaborative Screen to be developed by Aurora, Aurora will submit to Merck an invoice for *** of the date of such invoice.